Book your tickets now

An important update to the COVID-19 vaccine programme

+Educate
In print
Vaccines

An important update to the COVID-19 vaccine programme

July 2024
By Joan Ingram
Monday 1 July 2024, 12:15 AM
mRNACovidVax.PNG

Infectious disease physician Joan Ingram examines the new Comirnaty Omicron XBB.1.5 vaccine, including its effectiveness and safety

Key points, SARS-CoV-2 continues to cause hospitalisations and deaths, but at a lower rate than earlier in the pandemic as immunity increases. Comirnaty XBB.1.5, Education Blue W/ Grey Background W/ Padding
References
  • Andersson NW, Thiesson EM, Hviid A. Adverse events after XBB.1.5-containing COVID-19 mRNA vaccines. JAMA 2024;331(12):1057–59.
  • Gayed J, Diya O, Lowry FS, et al. Safety and immunogenicity of the monovalent Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine in individuals ≥12 years old: A phase 2/3 trial. Vaccines (Basel) 2024;12(2):118.
  • Hansen CH, Moustsen-Helms IR, Rasmussen M, et al. Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study. Lancet Infect Dis 2024;24(2):e73–74.
  • Link-Gelles R, Ciesla AA, Mak J, et al. Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARSCoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults – Increasing community access to testing program, United States, September 2023–January 2024. MMWR Morb Mortal Wkly Rep 2024;73(4):77–83.
  • Marking U, Bladh O, Aguilera K, et al. Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden. Lancet Infect Dis 2024;24(2):e80–81.
  • Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol 2023;21(6):361–79.
  • Therapeutic Goods Administration. COVID-19 vaccine safety report - 02-11-23.
  • WHO. Statement on the antigen composition of COVID-19 vaccines. 18 May 2023.
  • WHO. Statement on the antigen composition of COVID-19 vaccines. 13 December 2023.
  • WHO. Statement on the antigen composition of COVID-19 vaccines. 26 April 2024.

Class

FRAZ-polypharmacy-2025

CLASStime: Asthma management in 2025

Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment

Read more
Wednesday 14 May 2025, 12:45 AM
14 minutes to Read
More Class Articles

Latest news

Feats of the human body behind Tom Cruise’s stunts in Mission: Impossible movies

28/05/2025

‘Gutted’: Clinical pharmacists disheartened over Budget funding snub for comprehensive care teams

26/05/2025

Frustration as second NAAR meeting for 2025 gets delayed again

23/05/2025

Pharmacy leaders cautiously supportive of 12-month prescriptions

22/05/2025

Prescription changes benefit patients but not practices: GenPro leader Angus Chambers

22/05/2025

It’s an austerity Budget for Māori providers 

22/05/2025

Hosted Content 2

Mythbusting with Nicorette

Mythbusting with Nicorette®

Ever heard these myths from smokers?

Read more
Supplied by Kenvue
Tuesday 13 May 2025, 08:30 AM
1 minute to Read

Facebook

Pharmacy Today

Latest issue

PT May 2025 cover

May 2025

View all issues